Clinical Trial Update: Clinical Study on Acetyl-L-Carnitine [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial studying Acetyl-L-Carnitine for Peripheral Sensory Neuropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Sensory Neuropathy

Drugs mentioned

• Acetyl-L-carnitine (N-acetyl-L-carnitine)

Snippet

Sponsor: Lee's Pharmaceutical Limited | Conditions: Peripheral Sensory Neuropathy | Phase 3 | Status: COMPLETED